Scientific Advisory Board(SAB)

Christophe Queva, Ph.D.

Professional Experience

• 2017 - Present Oncorus Inc., Chief Scientific Officer and Senior Vice President, Research
• 2017 - Present BPI France, Consultant & Venture Partner
• 2015 - 2017 iTeos Therapeutics, Chief Scientific Officer
• 2012 - 2015 BioteQ Consulting LLC., Founder
• 2012 - 2015 Gilead Sciences, Director of Biology, Translational Medicine, Oncology and Inflammation
• 2006 - 2011 Amgen, Research Director of Oncology-Hematology Therapeutic Area
• 2001 - 2006 AstraZeneca Oncology, Associate Director
• 1998 - 2001 AstraZeneca Transgenics and Comparative Genomics, Associate Director
• 1993 -1998 Fred Hutchinson Cancer Research Center, Robert N. Eisenman’s Laboratory, Post-doctoral Research Fellow
• 1990 - 1992 University of Lille, Animal and Developmental Biology, Undergraduate Lecturer

Education

• University of Lille, France, Life and Health Sciences, Ph.D.
• University of Lille, France, Cell Biology, M.Sc.
• University of Lille, France, Biochemistry, M.Sc.
• University of Lille, France, Cell Biology and Physiology, B.S.
• University of Lille, France, Biochemistry, B.S.